DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 49 · January 2011 DOI: 10.1055/s-002-21608


27. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Regensburg, 28.–29. Januar 2011

Prof. Dr. Hans-Jürgen Schlitt

P4_02
Bakshi, R; Heidrich, B; Calle Serrano, B; Pothakamuri, SV; Manns, MP; Wedemeyer, H; Cornberg, M; Schlaphoff, V: Hepatitis C virus (HCV)-specific CD8 T-cells in HCV-seronegative individuals: Frequency and T-cell receptor repertoire (TCR)
P4_04
Berg, T; Buggisch, P; Malinski, P; Diepolder, H; Mauss, S; Rasenack, J; Goeser, T; Schmidt, WE; Kauffman, R; Beumont-Mauviel, M; Decker-Burgard, S; Zeuzem, S: Treatment of Genotype 1 HCV Treatment-Naïve Patients: final results of phase III study ADVANCE
P4_05
Böttcher, J; Hegenbarth, S; Stabenow, D; Busch, DH; van Endert, P; Kolanus, W; Kurts, C; Schultze, JL; Diehl, L; Knolle, PA: A novel memory function of tolerant CD8+ T cells in anti-microbial immunity
P4_06
Bröring, R; Real, C; Jahn-Hofmann, K; Ickenstein, L; John, M; Kleinehr, K; Gerken, G; Schlaak, JF: The non-specific activation of liver tissue by siRNAs in vivo can be controlled by chemical ribose modifications of siRNAs
P4_09
Calle Serrano, B; Jaroszewicz, J; Heidrich, B; Grabowski, J; Bremer, B; Deterding, K; Cornberg, M; Manns, MP; Wedemeyer, H: The role of HDV in the natural history of the persistent HBV infection
P4_10
P4_12
Dietz, J; Lutz, T; Knecht, G; Gute, P; Füller, C; Raziorrouh, B; Diepolder, H; Hofmann, WP; Zeuzem, S; Sarrazin, C: Sequenz-Evolution des HCV NS3/4A Protease Gens im Verlauf der akuten Hepatitis C Virus (HCV) Infektion
P4_13
Dorloff, C; Hemberger, J; Odenthal, M; Holzmann, H; Aberle, S; Drebber, U; Dienes, HP: Hepatitis E Virus in LeberBiopsien von Patienten mit akuter Hepatitis unbekannter Ätiologie
P4_15
Eisenhardt, M; Glässner, A; Krämer, B; Körner, C; Sauerbruch, T; Spengler, U; Nattermann, J: HCV-Core-induzierte Sekretion von CXCL10 führt zur Rekrutierung CXCR3(+) Natürlicher Killer-Zellen mit geringer zytotoxischer Aktivität
P4_16
Elanjimattom, S; Vermehren, J; Berger, A; Marzi, I; Lehmann, R; Hintereder, G; Zeuzem, S; Sarrazin, C: Hohe Prävalenz von Hepatitis C Virus-Antikörpern bei Patienten in der Zentralen Notaufnahme der J.W. Goethe Universitätsklinik, Frankfurt am Main
P4_17
Eurich, D; Boas-Knoop, S; Neuhaus, R; Somasundaram, R; Rühl, M; Neumann, UP; Neuhaus, P; Bahra, M; Seehofer, D: Association of Mannose-Binding-Lectin-2-gene Polymorphism to the Development of Hepatitis-C-induced Hepatocellular Carcinoma
P4_18
Farag, MMS; Tedjokusumo, R; Flechtenmacher, C; Asen, T; Stremmel, W; Protzer, U; Weigand, K: Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with Dendritic Cells pulsed by HBVsvp
P4_19
P4_20
Gärtner, K; Stabenow, D; Odenthal, M; Arnold, B; Hämmerling, G; Protzer, U; Dienes, HP; Kurts, C; Krönke, M; Knolle, PA: A novel non-MHC-I restricted CTL effector function mediated by TNF and XIAP
P4_21
Glässner, A; Eisenhardt, M; Krämer, B; Körner, C; Sauerbruch, T; Spengler, U; Nattermann, J: Natürliche Killer-Zellen aus HCV-infizierten Patienten induzieren effektiv Apoptose von aktivierten primären humanen hepatischen Sternzellen
P4_22
P4_23
Grimm, D; Neumann-Haefelin, C; Kersting, N; Blum, HE; Thimme, R: IL28B genotype and hepatitis C virus specific T cell response
P4_25
P4_28
Körner, C; Riesner, K; Krämer, B; Eisenhardt, M; Glässner, A; Sauerbruch, T; Nattermann, J; Spengler, U; Nischalke, HD: Die TRAIL-Rezeptor I-Polymorphismen C626G und A638C sind mit dem Auftreten eines hepatozellulären Karzinoms (HCC) bei chronischer Hepatitis C assoziiert
P4_29
P4_30
Lütgehetmann, M; Bornscheuer, T; Volz, T; Allweiss, L; Lohse, A; Petersen, J; Dandri, M: Hepatitis B virus Infection inhibits responsiveness to interferon alpha treatment in human hepatocytes in vivo
P4_31
Lutz, P; Wasmuth, JC; Nischalke, HD; Vidovic, N; Grünhage, F; Lammert, F; Oldenburg, J; Rockstroh, JK; Sauerbruch, T; Spengler, U: Der rs12979860 C/T-Polymorphismus des IL28B-Gen beeinflusst die Progression der Leberfibrose bei HIV positiven Patienten mit HCV Genotyp 1 Koinfektion
P4_32
P4_34
Nattermann, J; Timm, J; Nischalke, HD; Olbrich, A; Berg, T; Wedemeyer, H; Wiese, M; Roggendorf, M; Sauerbruch, T; Spengler, U: Einfluss des CCR5D32 Genotyps auf spontanen Verlauf der HCV-Infektion und prädiktiven Wert des IL28B-Polymorphismus in der Ostdeutschen Anti-D-Kohorte
P4_35
Peiseler, M; Sebode, M; Franke, B; Wortmann, F; Quaas, A; Schwinge, D; Weiler-Normann, C; Lohse, AW; Schramm, C; Herkel, J: The frequencies of Foxp3+ regulatory T cells in livers and peripheral blood of type I autoimmune hepatitis patients correlate with inflammatory activity
P4_38
Ruhl, M; Knuschke, T; Schewior, K; Wiese, M; Tenckhoff, H; Spengler, U; Nattermann, J; Hoffmann, D; Timm, J: CD8+ T cell selection pressure is a major driving force for evolution of hepatitis C virus nonstructural proteins
P4_39
Schildberg, FA; Wojtalla, A; Siegmund, SV; Diehl, L; Kurts, C; Knolle, PA: Hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism
P4_40
Schlaphoff, V; Lunemann, S; Pothakamuri, SV; Jaroszewicz, J; Grabowski, J; Pischke, S; Helfritz, FA; Manns, MP; Cornberg, M; Wedemeyer, H: The association of 2B4 up-regulation and SAP down-regulation indicates exhaustion of virus-specific CD8+ T cells
P4_42
P4_43
P4_44
Sprinzl, MF; Bührer, L; Strand, D; Schreiber, G; Galle, PR; Piehler, J; Schuchmann, M: Antiproliferative and antiviral effects of mutated IFN-alpha with increased IFN receptor binding affinity
P4_45
Sun, LA; Steinebrunner, N; Joschko, N; Langhein, A; Stremmel, W; Protzer, U; Müller-Schilling, M: The p53 family is involved in the elimination of Hepatitis B virus (HBV)-infected hepatocytes
P4_47
Volz, T; Allweiss, L; Lütgehetmann, M; Lohse, A; Matthes, E; Petersen, J; Dandri, M: Strong in vivo antiviral efficacy of a new L-deoxycytidine derivate in hepatitis B virus infected chimeric uPA mice
V4_02
Reiss, S; Rebhan, I; Backes, P; Longerich, T; Schirmacher, P; Bartenschlager, R; Lohmann, V: Enzymatic activity of Phosphatidyl-inositol-4 kinase III alpha (PI4KIIIα) is critically involved in HCV replication and regulated by HCV NS5A
V4_03
Jaroszewicz, J; Ho, H; Deterding, K; Markova, A; Wursthorn, K; Tillmann, HL; Schulz, S; Bock, TC; Manns, MP; Wedemeyer, H; Cornberg, M: Relevance of quantitative HBsAg (qHBsAg) during long-term treatment of chronic hepatitis B with nucleos(t)ide analogues (NUCs)